Medical News

RSS

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Dakim, Inc., the leader in cognitive therapy in the senior living market, has introduced BrainTrac, a new tool that monitors the cognitive performance of residents in senior living communities who use the Dakim BrainFitness system.

21 Jan 2014

As some states look to kill Obamacare, Maryland bill would boost enrollees

While legislators in at least seven states contemplate measures to stop implementation of the health law, Maryland's Senate advanced a bill to provide insurance to those who were unable to enroll in that state's troubled health exchange website.

21 Jan 2014

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $31.6 million debt financing expansion with Proteus Digital Health. The financing package, which was provided to Proteus Digital Health from both Oxford and Silicon Valley Bank, included a senior secured term loan and a revolving line of credit. Proceeds of the loan will be used for working capital growth.

21 Jan 2014

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

Novo Nordisk, a world leader in diabetes care, today announced the launch of the insulin delivery device NovoPen Echo in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory function that records the dose and time passed since the last injection.

From Novo Nordisk 21 Jan 2014

Three skilled nursing centers in Texas to provide free flu shots to seniors

Colonial Manor Cleburne, Advanced Healthcare of Garland and Winfield Rehab and Nursing, top-notch rehabilitation and skilled nursing centers, located in Cleburne, Garland, and Crockett, Texas, will be providing free flu shots to seniors 65 and above on January 22, 23 & 27 2014 from 10 AM - 2 PM.

21 Jan 2014

It Works! Global announces launch of first chewable dietary supplement

It Works! Global, a wellness products and lifestyle company, announced the launch of Greens Chew, a dietary supplement for antioxidant and prebiotic support.

21 Jan 2014

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

Trendlines Labs (a unit of the Trendlines Group) recently signed an agreement for collaboration with Roper St. Francis Healthcare.

21 Jan 2014

Healthways awarded contract to provide Get Healthy Service in Australia

Global well-being improvement leader Healthways announced today that it has been awarded a contract to provide Australia's largest health coaching program, Get Healthy Information and Coaching Service, in New South Wales, Tasmania, the Australian Capital Territory, Queensland and South Australia for the next three years.

21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.

21 Jan 2014

DATATRAK partners with Clinverse to reduce complexity and costs linked with clinical trials

DATATRAK International, Inc., a leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its newest DATATRAK Connect Technology Partner, Clinverse, Inc. Clinverse architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials.

21 Jan 2014

Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

Sigma-Aldrich Corporation, a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics.

21 Jan 2014

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to commence a pivotal, CE Mark registration trial for BL-5010P, for the non-surgical removal of benign skin lesions.

21 Jan 2014

NuPathe terminates merger agreement with Endo Health Solutions

Endo Health Solutions today announced that NuPathe Inc. has terminated its merger agreement with Endo. Endo has received a $5 million termination fee from NuPathe.

21 Jan 2014

PLSG reaches significant landmark in direct investments into life sciences companies

Pittsburgh Life Sciences Greenhouse, the region's only pure life sciences investment firm, and managing member of the PLSG Accelerator Fund, announced today it has made a $65,000 investment into Cohera Medical, Inc. which launches the organization into a $20 million milestone in total investments since the company's inception in 2001.

21 Jan 2014

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

Par Pharmaceutical Companies, Inc. today announced that it has entered into a definitive agreement to acquire JHP Group Holdings, the parent company of JHP Pharmaceuticals, a leading specialty pharmaceutical company that develops, manufactures and markets branded and generic sterile injectable products.

21 Jan 2014

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

ViiV Healthcare today announced that the European Commission has approved Tivicay (dolutegravir), an integrase inhibitor, for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

21 Jan 2014

First Edition: January 21, 2014

Today's headlines include news on the health law's implementation at both the federal and state levels.

21 Jan 2014

Football Fans in Training programme can help men lose weight, finds new research

An initiative that helps male football fans feel better and live a healthier lifestyle by losing weight, taking more exercise, and improving their diet has been a resounding success, according to new research published in The Lancet and BMC Public Health.

21 Jan 2014

Medical News

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

As some states look to kill Obamacare, Maryland bill would boost enrollees

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

Three skilled nursing centers in Texas to provide free flu shots to seniors

It Works! Global announces launch of first chewable dietary supplement

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

Healthways awarded contract to provide Get Healthy Service in Australia

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

DATATRAK partners with Clinverse to reduce complexity and costs linked with clinical trials

Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

NuPathe terminates merger agreement with Endo Health Solutions

PLSG reaches significant landmark in direct investments into life sciences companies

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

First Edition: January 21, 2014

Football Fans in Training programme can help men lose weight, finds new research

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News